Soluble levels of CD27 and CD30 are associated with risk of non‐Hodgkin lymphoma in three Chinese prospective cohorts

E-ISSN： 1097-0215|137|11|2688-2695

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.11, 2015-12, pp. : 2688-2695

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early viral complications following CD34‐selected autologous peripheral blood stem cell transplantation for non‐Hodgkin's lymphoma

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 1998-02 ,pp. : 348-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cervicofacial and Pulmonary Actinomycosis Associated with Non-Hodgkin's Lymphoma

By Dentale Nicola Fulgaro Ciro Fasulo Giovanni Guerra Luca Legnani Giorgio Mazzetti Magda Poletti Venerino Gritti Francesco M.

Scandinavian Journal of Infectious Diseases, Vol. 30, Iss. 5, 1998-12 ,pp. : 519-520

Informa Healthcare

Access to resources Recommend Favorite

Risk and outcome of non‐Hodgkin lymphoma among classical Hodgkin lymphoma survivors

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3385-3392

John Wiley & Sons Inc

Access to resources Recommend Favorite

Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma

By Valković Toni Duletić-Načinović Antica Štifter Sanja Hasan Milena Hadžisejdić Ita Zombori David Grahovac Blaženka Jonjić Nives

Clinical and Experimental Medicine, Vol. 10, Iss. 4, 2010-12 ,pp. : 229-235

Springer Publishing Company

Access to resources Recommend Favorite

The combination of milatuzumab, a humanized anti‐CD74 antibody, and veltuzumab, a humanized anti‐CD20 antibody, demonstrates activity in patients with relapsed and refractory B‐cell non‐Hodgkin lymphoma

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 5, 2015-06 ,pp. : 701-710

John Wiley & Sons Inc

Access to resources Recommend Favorite